Article Highlights
Novel acne drug now under review at the FDA
Stage I mycosis fungoides is the general dermatologist’s bailiwick
Oral propranolol shown safe in PHACE
Don’t call it perioral dermatitis
New topicals coming for pediatric atopic dermatitis
Dupilumab approval sought for AD under age 12
Merkel cell carcinoma management undergoes revolution
Short-course calcipotriol plus 5-FU for AKs: potential major public health impact
Isotretinoin data provide postmeal absorption guidance
Keep your eye on tapinarof, a topical antipsoriatic therapy
Studies add clarity to link between rosacea and Demodex, coffee
Data overwhelmingly support use of dermoscopy in practice
Morning and evening skin care: What to tell patients
Pondering jumping into teledermatology?
Patient counseling about what to expect with noninvasive skin tightening is key
Reassurance on general anesthesia in young kids
Data back botulinum toxin for facial flushing, androgenetic alopecia
Avoid ‘mutant selection window’ when prescribing antibiotics for acne
Vitiligo tied to lower risk of internal malignancies
Hyperhidrosis treatment options include glycopyrrolate
Rosacea: Target treatment to pathogenic pathway
Dupilumab for severe AD: Expert advocates continuous treatment
Sequential dermoscopy imaging helps find melanomas early
Five rules for evaluating melanonychia
Patch testing in atopic dermatitis: when and how
Consider 9-mm surgical margins for MIS
Use time-appropriate scar improvement sequencing
Derm MOC reboot welcomed
Rhymin’ pediatric dermatologist provides Demodex tips
TCA and punch excision are two options for icepick acne scars
Ixekizumab psoriasis outcomes, sliced and diced
Simple treatments can address bleeding in dermatologic surgery
Dupilumab conjunctivitis does not always require an ophthalmologist referral
What’s new with adalimumab? Plenty
Don’t miss early joint involvement in psoriasis
Tropical travelers’ top dermatologic infestations
How to surf the rosacea treatment algorithm